跳至主要内容
临床试验/TCTR20161212001
TCTR20161212001已完成4 期

The effectiveness of split tablet dosing versus alternate-day dosing of warfarin: A randomized control trial

Siriraj Research Development Fund (Managed by Routine to Research: R2R)0 个研究点目标入组 66 人开始时间: 2016年12月12日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • The anticoagulated patients who followed up at the outpatient clinic of the Division of Cardio-Thoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
  • Eligible patients had six months or longer history of stable therapeutic INR levels of 2.0 to 3.0 achieved by the specific weekly dose of warfarin in the dosage protocol (14, 17.5, 21, 24.5, 28, 31.5 mg/week) and could comply with 6 months follow up protocol.

排除标准

  • The patients whose a period of warfarin discontinuation was possibly needed were excluded.

研究者

发起方
Siriraj Research Development Fund (Managed by Routine to Research: R2R)

相似试验